ZA918876B - Avirulent microbes and uses therefor:salmonella typhi - Google Patents
Avirulent microbes and uses therefor:salmonella typhiInfo
- Publication number
- ZA918876B ZA918876B ZA918876A ZA918876A ZA918876B ZA 918876 B ZA918876 B ZA 918876B ZA 918876 A ZA918876 A ZA 918876A ZA 918876 A ZA918876 A ZA 918876A ZA 918876 B ZA918876 B ZA 918876B
- Authority
- ZA
- South Africa
- Prior art keywords
- immunogenic compositions
- invertebrate
- vertebrate
- typhi
- immunogenic
- Prior art date
Links
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 title abstract 3
- 230000002163 immunogen Effects 0.000 abstract 6
- 239000000203 mixture Substances 0.000 abstract 5
- 241000251539 Vertebrata <Metazoa> Species 0.000 abstract 3
- 239000000427 antigen Substances 0.000 abstract 2
- 108091007433 antigens Proteins 0.000 abstract 2
- 102000036639 antigens Human genes 0.000 abstract 2
- 230000003053 immunization Effects 0.000 abstract 2
- 238000002649 immunization Methods 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 244000052769 pathogen Species 0.000 abstract 2
- 230000001717 pathogenic effect Effects 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 230000028993 immune response Effects 0.000 abstract 1
- 210000000987 immune system Anatomy 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 230000035772 mutation Effects 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0275—Salmonella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/255—Salmonella (G)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/01—Preparation of mutants without inserting foreign genetic material therein; Screening processes therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/42—Salmonella
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US61200190A | 1990-11-09 | 1990-11-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA918876B true ZA918876B (en) | 1992-08-26 |
Family
ID=24451304
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA918876A ZA918876B (en) | 1990-11-09 | 1991-11-08 | Avirulent microbes and uses therefor:salmonella typhi |
Country Status (14)
| Country | Link |
|---|---|
| EP (2) | EP0556333B1 (xx) |
| JP (2) | JP3601602B2 (xx) |
| CN (1) | CN1063416A (xx) |
| AT (1) | ATE234917T1 (xx) |
| AU (1) | AU666108B2 (xx) |
| CA (1) | CA2095534C (xx) |
| DE (1) | DE69133219T2 (xx) |
| DK (1) | DK0556333T3 (xx) |
| ES (1) | ES2194837T3 (xx) |
| IE (1) | IE913912A1 (xx) |
| IL (1) | IL100010A (xx) |
| NZ (1) | NZ240538A (xx) |
| WO (1) | WO1992008486A1 (xx) |
| ZA (1) | ZA918876B (xx) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9326425D0 (en) * | 1993-12-24 | 1994-02-23 | Secr Defence | Vaccine compositions |
| GB9621091D0 (en) | 1996-10-09 | 1996-11-27 | Fondation Pour Le Perfectionem | Attenuated microorganisms strains and their uses |
| EP2150616A4 (en) | 2007-05-10 | 2011-07-27 | Univ Arizona | REGULATED ANTIGEN SYNTHESIS AND / OR REGULATED ATTENUATION FOR IMPROVING VACCINATE IMMUNOGENICITY AND / OR SAFETY |
| WO2009046449A1 (en) | 2007-10-05 | 2009-04-09 | The Arizona Board Of Regents For And On Behalf Of Arizona State University | Recombinant bacterium capable of eliciting an immune response against enteric pathogens |
| WO2010045620A1 (en) | 2008-10-17 | 2010-04-22 | The Arizona Board Of Regents For And On Behalf Of Arizona State University | Recombinant bacterium capable of eliciting an immune response against streptococcus pneumoniae |
| US9163219B2 (en) | 2009-04-14 | 2015-10-20 | Arizona Board Of Regents On Behalf Of Arizona State University | Single expression vector for generation of a virus with a segmented genome |
| WO2010135563A1 (en) | 2009-05-22 | 2010-11-25 | The Arizona Board Of Regents For And On Behalf Of Arizona State University | Recombinant bacterium and methods of antigen and nucleic acid delivery |
| US9045742B2 (en) | 2009-05-29 | 2015-06-02 | The Arizona Board Of Regents For And On Behalf Of Arizona State University | Recombinant Edwardsiella bacterium |
| US9062297B2 (en) | 2010-01-13 | 2015-06-23 | The Arizona Board Of Regents For And On Behalf Of Arizona State University | Yersinia pestis vaccine |
| US8889121B2 (en) | 2010-01-22 | 2014-11-18 | The Arizona Board Of Regents For An On Behalf Of Arizona State University | Bacterium comprising a regulated rfaH nucleic acid |
| US9598697B2 (en) | 2010-05-28 | 2017-03-21 | The Arizona Board Of Regents For And On Behalf Of Arizona State University | Recombinant bacterium to decrease tumor growth |
| US9303264B2 (en) | 2012-05-18 | 2016-04-05 | The Arizona Board Of Regents For And On Behalf Of Arizona State University | Photosynthetic microorganisms expressing thermostable lipase |
| US9580718B2 (en) | 2013-06-17 | 2017-02-28 | Arizona Board Of Regents On Behalf Of Arizona State University | Attenuated live bacteria with increased acid resistance and methods of use thereof |
| RU2707548C1 (ru) * | 2019-01-24 | 2019-11-27 | Федеральное бюджетное учреждение науки "Санкт-Петербургский научно-исследовательский институт эпидемиологии и микробиологии им. Пастера Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека" (ФБУН НИИ эпидемиологии и микробиологии имени Пастера) | Штамм бактерий salmonella enterica subsp. enterica serovar typhi b-8453 с устойчивостью низкого уровня к фторхинолонам, используемый в качестве контрольного штамма для фенотипических и молекулярных исследований при диагностике брюшного тифа |
| RU2759396C1 (ru) * | 2020-12-22 | 2021-11-12 | Федеральное государственное бюджетное учреждение "Всероссийский государственный Центр качества и стандартизации лекарственных средств для животных и кормов" (ФГБУ "ВГНКИ") | Штамм бактерий salmonella enterica (вкшм-б-849м) в качестве контрольного штамма для микробиологических и молекулярно-генетических исследований в определении антибиотикорезистентности |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4550081A (en) * | 1980-05-19 | 1985-10-29 | The Board Of Trustees Of The Leland Stanford Jr. University | Non-reverting salmonella |
| US4888170A (en) * | 1981-10-22 | 1989-12-19 | Research Corporation | Vaccines obtained from antigenic gene products of recombinant genes |
| CA1338705C (en) * | 1981-10-22 | 1996-11-12 | Roy Curtiss Iii | Vaccines obtained from antigenic gene products of recombinant genes |
| AU589114B2 (en) * | 1984-02-01 | 1989-10-05 | Enterovax Limited | Genetically engineered bacteria useful as a vaccine |
| IL86583A0 (en) * | 1987-06-04 | 1988-11-15 | Molecular Eng Ass | Vaccine containing a derivative of a microbe and method for the production thereof |
| WO1989003427A1 (en) * | 1987-10-07 | 1989-04-20 | Washington University | A method of maintaining a desired recombinant gene in a genetic population of cells |
| DE69027313T2 (de) * | 1989-03-31 | 1997-01-23 | Univ Washington | Impfstoffe enthaltende avirulente phop-type mikroorganismen |
| EP0465561A4 (en) * | 1989-03-31 | 1992-04-08 | Washington University | Avirulent microbes and uses therefor |
| WO1992009684A1 (en) * | 1990-11-21 | 1992-06-11 | Washington University | Recombinant avirulent salmonella antifertility vaccines |
-
1991
- 1991-11-08 ES ES92901722T patent/ES2194837T3/es not_active Expired - Lifetime
- 1991-11-08 CA CA002095534A patent/CA2095534C/en not_active Expired - Fee Related
- 1991-11-08 ZA ZA918876A patent/ZA918876B/xx unknown
- 1991-11-08 WO PCT/US1991/008376 patent/WO1992008486A1/en active IP Right Grant
- 1991-11-08 IE IE391291A patent/IE913912A1/en not_active IP Right Cessation
- 1991-11-08 DE DE69133219T patent/DE69133219T2/de not_active Expired - Fee Related
- 1991-11-08 EP EP92901722A patent/EP0556333B1/en not_active Expired - Lifetime
- 1991-11-08 EP EP03006123A patent/EP1323428A3/en not_active Withdrawn
- 1991-11-08 IL IL100010A patent/IL100010A/en not_active IP Right Cessation
- 1991-11-08 AU AU91204/91A patent/AU666108B2/en not_active Ceased
- 1991-11-08 DK DK92901722T patent/DK0556333T3/da active
- 1991-11-08 JP JP50226592A patent/JP3601602B2/ja not_active Expired - Fee Related
- 1991-11-08 AT AT92901722T patent/ATE234917T1/de not_active IP Right Cessation
- 1991-11-09 CN CN91111876A patent/CN1063416A/zh active Pending
- 1991-11-11 NZ NZ240538A patent/NZ240538A/xx not_active IP Right Cessation
-
2004
- 2004-07-14 JP JP2004207489A patent/JP2004337175A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| ES2194837T3 (es) | 2003-12-01 |
| WO1992008486A1 (en) | 1992-05-29 |
| AU9120491A (en) | 1992-06-11 |
| IL100010A0 (en) | 1992-08-18 |
| JP2004337175A (ja) | 2004-12-02 |
| JPH06501849A (ja) | 1994-03-03 |
| IE913912A1 (en) | 1992-05-20 |
| EP0556333A1 (en) | 1993-08-25 |
| EP1323428A2 (en) | 2003-07-02 |
| CA2095534A1 (en) | 1992-05-10 |
| EP0556333A4 (en) | 1994-10-12 |
| ATE234917T1 (de) | 2003-04-15 |
| CN1063416A (zh) | 1992-08-12 |
| AU666108B2 (en) | 1996-02-01 |
| DE69133219T2 (de) | 2004-02-12 |
| DE69133219D1 (de) | 2003-04-24 |
| JP3601602B2 (ja) | 2004-12-15 |
| EP0556333B1 (en) | 2003-03-19 |
| EP1323428A3 (en) | 2003-09-17 |
| IL100010A (en) | 1998-02-08 |
| NZ240538A (en) | 1994-01-26 |
| CA2095534C (en) | 2002-09-17 |
| DK0556333T3 (da) | 2003-07-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA918876B (en) | Avirulent microbes and uses therefor:salmonella typhi | |
| AU1955088A (en) | Avirulent microbes, incapable of producing functional adenylate cyclase and cyclic AMP | |
| AU2785089A (en) | Chimeric glycoproteins containing immunogenic segments of the glycoproteins of human respiratory syncytial virus | |
| KR970707281A (ko) | 풀리뉴클레오티드 결핵 백신(A polynucleotide tuberculosis vaccine) | |
| CA2231603A1 (en) | Chicken interleukin-15 and uses thereof | |
| LU91610I2 (fr) | Protéine D et ses dérivés pharmaceutiquement acceptables (SYNFLORIX - Vaccin pneumococcique polysaccharidique conjugé (adsorbé) | |
| ES8505719A1 (es) | Procedimiento de preparar mutantes de delecion vivos y metodo de preparar vacunas | |
| KR970009347B1 (en) | Chimeric glycoproteins containing immunogenic segments of human parainfluenza virus type 3 | |
| DE60038099T2 (de) | Neisseria impfstoffzusammensetzungen und methoden | |
| Sory et al. | Yersinia enterocolitica O: 9 as a potential live oral carrier for protective antigens | |
| FI932759A (fi) | Anvaendningen av il-4 foer oekning av pao vacciners immunogener verkande immunreaktioner | |
| US20030021812A1 (en) | Neisserial vaccine compositions and methods | |
| Menon et al. | Mycobacterial ESAT-6 protein enhances mouse IFN-γ responses to Mycoplasma hyopneumoniae P71 protein | |
| ES8105394A1 (es) | Procedimiento para la preparacion de cepas mutantes para va-cunacion | |
| Dorner et al. | Bacterial toxin vaccines | |
| Curtis et al. | Avirulent microbes and uses thereof | |
| EP0186368A3 (en) | Biological preparations | |
| Pai et al. | A Comparison of the Subcutaneous and Intradermal Methods of Immunization with TAB Vaccine—An Experimental Study | |
| Micalizzi et al. | Protective Activity of Different Immunosera AgainstClostridium chauvoei | |
| Mukerjee et al. | Effect of adjuvants on immunization with dengue virus-induced cytotoxic factor | |
| Gibbons et al. | Antigenic variation in populations of oral streptococci | |
| CA2051829A1 (en) | Gene encoding a 30-kilodalton outer membrane protein of bordetella pertussis | |
| RU93043610A (ru) | Фармацевтическая композиция для усиления первичной иммуно-реакции у млекопитающих, способ усиления первичной иммуно-реакции и применение интерлейкина-4 для усиления первичной иммуно-реакции у млекопитающих, набор лекарственных средств |